Eye Movement and Cognitive Dysfunction (EMCD)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04236375|
Recruitment Status : Not yet recruiting
First Posted : January 22, 2020
Last Update Posted : January 22, 2020
|Condition or disease|
|Eye Movement Disorder Cognitive Dysfunction|
|Study Type :||Observational|
|Estimated Enrollment :||700 participants|
|Official Title:||The Development of an Artificial Intelligence Platform for Screening and Referral of Cognitive Dysfunction|
|Estimated Study Start Date :||February 1, 2020|
|Estimated Primary Completion Date :||August 1, 2020|
|Estimated Study Completion Date :||December 1, 2020|
Subjects over 45 years old without cognitive dysfunction
Mild cognitive decline
Subjects who are diagnosed as mild cognitive decline(MCI) according to neurologists.
Subjects who are diagnosed as Alzheimer's disease(AD) according to neurologists.
Subjects who are diagnosed as vascular dementia(VD) according to neurologists.
Lewy body dementia
Subjects who are diagnosed as Lewy body demenita (DLB) according to neurologists.
Subjects who are diagnosed as Frontotemporal demenita (FD) according to neurologists.
Subjects who are diagnosed as dementia but are not as AD, VD, DLB OR FD.
- Area under the curve [ Time Frame: up to 1 month ]AUC values for predicting whether subject has cognitive impairment or not
- Accuracy, true positive rate, and true negetive rate [ Time Frame: up to 1 month ]The performance of this artificial platform
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04236375
|Contact: Haotian Lin, M.D.,Ph.Demail@example.com|
|Study Chair:||Haotian Lin, M.D.,Ph.D||Zhongshan Ophthalmic Center, Sun Yat-sen University|
|Study Director:||Xun Wang, M.D.,Ph.D||Zhongshan Ophthalmic Center, Sun Yat-sen University|
|Principal Investigator:||Shuyi Zhang, M.D.||Zhongshan Ophthalmic Center, Sun Yat-sen University|